Digital Engagement and NPP for Pharma During the COVID-19 Pandemic


Launching a new medication in a complex disease state is fraught with complications that can impact medication adherence. New medications that can greatly improve a patient’s quality of life and overall health can present significant side effects that often lead patients to abandon treatment. When patients are faced with a life-threatening disease, unexpected or misunderstood side effects from medication can trigger fear that the medication is having an adverse effect, or worsening their condition.
In this webinar we’ll discuss innovative and best-in-practice approaches to new drug launches that explore the art, science, and psychology to treatment and medication adherence. Join this incredible panel of industry experts and thought leaders with decades of experience in innovative drug launches. We’ll explore the complexities and opportunities for life science companies to deliver new programs that achieve positive outcomes – for patients and their care teams.

During this webinar our panelists will review a special case study of a highly successful patient engagement program that combined nurse support with text-based communication, leading to over 34% engagement and averaging 14 minutes per session. This innovative program helped patients successfully navigate the side effects of treatment and stay adherent on life extending therapy. The industry benchmarks for patient engagement and adherence are being redefined by such programs


Meet the thought leaders

Avatar for Karima Sharif MBA

Karima Sharif MBA

Group Vice President, Publicis Health Media
Avatar for Steve Silvestro

Steve Silvestro

Chief Commercial Officer, OptimizeRx
Avatar for Paul Ivans

Paul Ivans

Chief Executive Officer, Evolution Road
Avatar for Eze Abosi

Eze Abosi

Head, Real World Evidence Solutions, OptimizeRx